Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RYTM
Stock Latest News
The Fly
Rhythm Pharmaceuticals price target raised to $140 from $120 at Guggenheim
2d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $157 from $141 at Goldman Sachs
7d ago
RYTM
Premium
Ratings
Promising Clinical Results and Market Potential Drive Buy Rating for Rhythm Pharmaceuticals
7d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $141 from $114 at Canaccord
7d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $167 from $141 at Citizens
7d ago
RYTM
Premium
The Fly
Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals
7d ago
PTN
RYTM
Premium
Ratings
Promising Phase 2 Results for Rhythm Pharmaceuticals’ Setmelanotide in Prader-Willi Syndrome Boost Buy Rating
8d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $150 from $129 at Morgan Stanley
8d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals rises 15.6%
8d ago
RYTM
Premium
Ratings
Positive Phase 2 Trial Results Boost Rhythm Pharmaceuticals’ Outlook and Price Target
8d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $140 from $127 at BofA
8d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals rises 11.4%
8d ago
RYTM
Premium
Company Announcements
Rhythm Pharmaceuticals Announces Positive Phase 2 Trial Results
8d ago
8K
RYTM
Premium
The Fly
Rhythm Pharmaceuticals’ setmelanotide shows efficacy in Phase 2 PWS trial
8d ago
RYTM
Premium
The Fly
Brinker upgraded, Coinbase downgraded: Wall Street’s top analyst calls
24d ago
Q
EL
Premium
The Fly
Rhythm Pharmaceuticals initiated with a Buy at Citi
24d ago
RYTM
Premium
The Fly
Rhythm announces presentation of four datasets at ObesityWeek
1M ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $114 from $105 at Canaccord
1M ago
RYTM
Premium
Ratings
Positive Outlook for Rhythm Pharmaceuticals Despite FDA Review Delay and Financial Shortfall
1M ago
RYTM
Premium
Company Announcements
Rhythm Pharmaceuticals Faces FDA Review Extension
1M ago
8K
RYTM
Premium
The Fly
Rhythm announces FDA extension of review period for IMCIVREE
1M ago
RYTM
Premium
Company Announcements
Rhythm Pharmaceuticals’ Earnings Call Highlights Growth and Optimism
1M ago
RYTM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
